COVID-19 cases in Latin America 2024, by country

Brazil is the Latin American country affected the most by the COVID-19 pandemic. As of July 2024, the country had reported around 38 million cases. It was followed by Argentina, with approximately ten million confirmed cases of COVID-19. In total, the region had registered more than 83 million diagnosed patients, as well as a growing number of fatal COVID-19 cases.The research marathonNormally, the development of vaccines takes years of research and testing until options are available to the general public. However, with an alarming and threatening situation as that of the COVID-19 pandemic, scientists quickly got on board in a vaccine marathon to develop a safe and effective way to prevent and control the spread of the virus in record time. Over two years after the first cases were reported, the world had around 1,521 drugs and vaccines targeting the COVID-19 disease. As of June 2022, a total of 39 candidates were already launched and countries all over the world had started negotiations and acquisition of the vaccine, along with immunization campaigns. COVID vaccination rates in Latin AmericaAs immunization against the spread of the disease continues to progress, regional disparities in vaccination coverage persist. While Brazil, Argentina, and Mexico were among the Latin American nations with the most COVID-19 cases, those that administered the highest number of COVID-19 doses per 100 population are Cuba, Chile, and Peru. Leading the vaccination coverage in the region is the Caribbean nation, with more than 406 COVID-19 vaccines administered per every 100 inhabitants as of January 5, 2024.For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

巴西是受COVID-19疫情影响最为严重的拉丁美洲国家。截至2024年7月，该国已报告约3800万例病例。紧随其后的是阿根廷，约有1000万例COVID-19确诊病例。整个地区共登记超过8300万例确诊患者，以及不断上升的COVID-19死亡病例。疫苗研发的马拉松式进程通常，疫苗的研发和测试需要数年的深入研究，直至公众可获取相关选项。然而，面对COVID-19疫情的紧迫与威胁，科学家们迅速投入到疫苗研发的马拉松式竞争中，以期在极短的时间内开发出一种安全有效的预防与控制病毒传播的方法。自首例病例报告以来，两年有余，全球已有约1521种针对COVID-19疾病的药物和疫苗。截至2022年6月，已有39种候选疫苗投入使用，世界各国开始进行疫苗的谈判和采购，并启动了疫苗接种活动。拉丁美洲的COVID疫苗接种率在疫苗接种继续推进以遏制疾病传播的过程中，区域间的疫苗接种覆盖率仍存在显著差异。尽管巴西、阿根廷和墨西哥是拉丁美洲病例最多的国家之一，但每百人口接种COVID-19疫苗剂量最多的国家依次为古巴、智利和秘鲁。截至2024年1月5日，加勒比地区国家在疫苗接种覆盖率方面位居该区域首位，每百名居民已接种406剂COVID-19疫苗。如需进一步了解关于冠状病毒（COVID-19）疫情的信息，请访问我们的专门数据与事实页面。